Loading...
Quanterix reported Q2 2021 GAAP revenue of $25.4 million and non-GAAP revenue of $24.4 million, representing an 86% increase over the prior year. Instrument placements also increased by 71%.
Q2 GAAP revenue was $25.4 million, including Grant Revenue.
Q2 Non-GAAP revenue was $24.4 million, an increase of 86% over the prior year.
Instrument placements increased by 71%.
The company is strategically expanding in the diagnostics space, particularly for neurodegenerative diseases like Alzheimer's.
No specific forward guidance was provided in the press release.